Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 406-407
DOI: 10.1111/apt.70754 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-05-22. Written by Takashi Kumada and 4 co-authors. Institution: Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan. 10 references. The full text is freely available in PubMed Central.
Abstract (original language)
Niciun rezumat disponibil.
Authors and institutions
- Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
- Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
- Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
ORCID profiles: Takashi Kumada, Masanori Atsukawa, Taeang Arai, Hidenori Toyoda, Junko Tanaka
Cite
APA
Kumada, T., Atsukawa, M., Arai, T., Toyoda, H., & Tanaka, J. (2026). Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(3), 406-407. https://doi.org/10.1111/apt.70754
Vancouver
Kumada T, Atsukawa M, Arai T, Toyoda H, Tanaka J. Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(3):406-407. doi:10.1111/apt.70754
BibTeX
@article{Kumada2026,
author = {Kumada, Takashi and Atsukawa, Masanori and Arai, Taeang and Toyoda, Hidenori and Tanaka, Junko},
title = {Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {3},
pages = {406--407},
doi = {10.1111/apt.70754}
}
EUVIMED